NO930401L - Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav - Google Patents

Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav

Info

Publication number
NO930401L
NO930401L NO93930401A NO930401A NO930401L NO 930401 L NO930401 L NO 930401L NO 93930401 A NO93930401 A NO 93930401A NO 930401 A NO930401 A NO 930401A NO 930401 L NO930401 L NO 930401L
Authority
NO
Norway
Prior art keywords
methods
hiv infections
peptides
blocking hiv
infected
Prior art date
Application number
NO93930401A
Other languages
English (en)
Norwegian (no)
Other versions
NO930401D0 (no
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Syntello Vaccine Dev Kb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Vaccine Dev Kb filed Critical Syntello Vaccine Dev Kb
Publication of NO930401D0 publication Critical patent/NO930401D0/no
Publication of NO930401L publication Critical patent/NO930401L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO93930401A 1990-08-22 1993-02-05 Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav NO930401L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57108090A 1990-08-22 1990-08-22
PCT/SE1991/000544 WO1992003147A1 (en) 1990-08-22 1991-08-20 Peptides that block human immunodeficiency virus infections and methods of use thereof

Publications (2)

Publication Number Publication Date
NO930401D0 NO930401D0 (no) 1993-02-05
NO930401L true NO930401L (no) 1993-02-17

Family

ID=24282265

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930401A NO930401L (no) 1990-08-22 1993-02-05 Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav

Country Status (17)

Country Link
EP (1) EP0545991B1 (de)
JP (1) JP3115596B2 (de)
KR (1) KR100220531B1 (de)
AT (1) ATE173934T1 (de)
AU (1) AU667290B2 (de)
BR (1) BR9106772A (de)
CA (1) CA2088788C (de)
DE (1) DE69130571T2 (de)
DK (1) DK0545991T3 (de)
ES (1) ES2128322T3 (de)
FI (1) FI930519L (de)
GR (1) GR3029523T3 (de)
HU (1) HUT63177A (de)
MC (1) MC2306A1 (de)
NO (1) NO930401L (de)
OA (1) OA10051A (de)
WO (1) WO1992003147A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101370509A (zh) * 2006-01-13 2009-02-18 安克瑞格公司 化合物连同γ辐射在用于治疗癌症中的应用
FR2925501B1 (fr) * 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925500B1 (fr) * 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3781272A (en) 1972-03-24 1973-12-25 Abbott Lab Tripeptide
US3803117A (en) 1972-03-24 1974-04-09 Abbott Lab Tetrapeptide
ATE108022T1 (de) * 1985-10-24 1994-07-15 Southwest Found Biomed Res Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
AU8433291A (en) 1992-03-17
FI930519A7 (fi) 1993-04-21
HUT63177A (en) 1993-07-28
HU9300456D0 (en) 1993-05-28
FI930519L (fi) 1993-04-21
EP0545991A1 (de) 1993-06-16
JPH06504035A (ja) 1994-05-12
GR3029523T3 (en) 1999-06-30
NO930401D0 (no) 1993-02-05
EP0545991B1 (de) 1998-12-02
DE69130571D1 (de) 1999-01-14
ATE173934T1 (de) 1998-12-15
AU667290B2 (en) 1996-03-21
ES2128322T3 (es) 1999-05-16
DE69130571T2 (de) 1999-06-17
JP3115596B2 (ja) 2000-12-11
BR9106772A (pt) 1993-07-20
MC2306A1 (fr) 1993-09-27
KR100220531B1 (ko) 1999-10-01
CA2088788A1 (en) 1992-02-23
DK0545991T3 (da) 1999-08-16
WO1992003147A1 (en) 1992-03-05
FI930519A0 (fi) 1993-02-05
CA2088788C (en) 2003-12-16
OA10051A (en) 1996-10-14

Similar Documents

Publication Publication Date Title
ATE476984T1 (de) Behandlung von herpes infektion mit anwendung von immunomodulatore polynukleotide sequenzen
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
TR199903053T2 (xx) Benzimidazol t�revleri.
DK0683669T3 (da) Fremgangsmåder og præparater af en polymer (poloxamer) til cellereparation
DE69829175D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
BG97068A (bg) Фармацевтичен състав и метод за постигане на терапевтичен ефект
EP1852121A3 (de) Flüssige Analoge zur Behandlung viraler Infektionen
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
AU5537096A (en) Isolated frpb nucleic acid molecule and vaccine
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
NO984760D0 (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
NO930401L (no) Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav
DK0859613T3 (da) Anvendelse af flupirtin til forebyggelse og behandling af sygdomme, som er forbundet med beskadigelse af det hæmopoietiske cellesystem
ATE189460T1 (de) Gegen protozoen wirksamezyklische tetrapeptide
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
DK0687181T3 (da) Metode til behandling af hepatitis C hos individer, som ikke responderer på interferon-behandling
NZ256246A (en) Serine leukocyte protease inhibitor, recombinant preparation thereof, and treatment of a retroviral infection
AU2396900A (en) Treatment and prevention of hiv and other viral infections
WO1993014760A3 (en) Methods
RU93005034A (ru) Пептиды, блокирующие инфекцию вируса иммунодефицита человека, способы их применения
EP0133599A3 (de) Vakzine und Zubereitungen gegen Hepatitis B virale Infektionen